Neurocrine Biosciences (NBIX) Accumulated Expenses (2010 - 2019)
Neurocrine Biosciences (NBIX) posted quarterly Accumulated Expenses of $46.2 million for Q4 2019, up 20.41% year-over-year from $38.4 million in Q4 2018, and up 20.41% on a QoQ basis from $38.4 million in Q4 2018.
Neurocrine Biosciences (NBIX) Accumulated Expenses (2010 - 2019) Analysis & Trends
Neurocrine Biosciences has reported Accumulated Expenses for 10 years, with the latest figure at $46.2 million in Q4 2019.
- Accumulated Expenses for Q4 2019 came in at $46.2 million, up 20.41% year-over-year; the trailing twelve-month figure through Dec 2019 was $46.2 million (up 20.41% YoY), and the FY2019 annual result was $46.2 million, up 20.41% from the prior year.
- Accumulated Expenses advanced to $46.2 million in Q4 2019, from $38.4 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $46.2 million in Q4 2019 and troughed at $9.6 million in Q4 2016.
- A 5-year average of $21.0 million and a median of $18.7 million in 2015 frame the typical range for Accumulated Expenses.
- The widest annual swing landed in 2016, when Accumulated Expenses sank 49.78%; it then soared 160.5% in 2017.
- A 5-year view of Accumulated Expenses shows it stood at $19.0 million in 2015, then slumped by 49.78% to $9.6 million in 2016, then soared by 160.5% to $24.9 million in 2017, then jumped by 54.13% to $38.4 million in 2018, then gained by 20.41% to $46.2 million in 2019.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $46.2 million in Q4 2019, $38.4 million in Q4 2018, and $24.9 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 38.94 Mn |
| Dec 31, 2018 | 27.34 Mn |
| Dec 31, 2017 | 24.90 Mn |
| Mar 31, 2017 | 18.40 Mn |
| Dec 31, 2016 | 9.56 Mn |
| Sep 30, 2016 | 20.75 Mn |
| Jun 30, 2016 | 21.02 Mn |
| Mar 31, 2016 | 17.13 Mn |
| Dec 31, 2015 | 7.36 Mn |
| Sep 30, 2015 | 14.51 Mn |
| Jun 30, 2015 | 12.39 Mn |
| Mar 31, 2015 | 9.94 Mn |
| Dec 31, 2014 | 11.51 Mn |
| Sep 30, 2014 | 9.31 Mn |
| Jun 30, 2014 | 7.44 Mn |
| Mar 31, 2014 | 6.11 Mn |
| Dec 31, 2013 | 3.40 Mn |
| Sep 30, 2013 | 7.88 Mn |
| Jun 30, 2013 | 8.19 Mn |
| Mar 31, 2013 | 6.58 Mn |